Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice

BACKGROUND: Major bleeding after acute coronary syndrome predicts a poor outcome but is challenging to define. The choice of antiplatelet influences bleeding risk. METHODS AND RESULTS: Major bleeding, subsequent myocardial infarction (MI), and all‐cause mortality to 1 year were compared in consecuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mullen, Liam, Meah, Mohammed N., Elamin, Ahmed, Aggarwal, Suneil, Shahzad, Adeel, Shaw, Matthew, Hasara, Jaroslav, Rashid, Muhammad, Fisher, Michael, Ali, Turab, Patel, Billal, Ding, Wern Y., Grainger, Ruth, Heseltine, Thomas, Kirmani, Bilal H., Obeidat, Mohammed, Kasolo, Yande, Thatchil, Jecko, Khand, Aleem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174168/
https://www.ncbi.nlm.nih.gov/pubmed/33834845
http://dx.doi.org/10.1161/JAHA.120.019467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174168/
https://www.ncbi.nlm.nih.gov/pubmed/33834845
http://dx.doi.org/10.1161/JAHA.120.019467

Ejemplares similares